Table 3 Clinical characteristics of PREVEND participants with the FLI ≥ 60 according to AAA-1 status
|  | Overall (n = 112) | AAA-1 negative (n = 78) | AAA-1 positive (n = 34) | P-value |
|---|---|---|---|---|
Demographic | ||||
 Age, yr | 59 (50.5–69) | 58.5 (50–70) | 62 (52–67) | 0.615 |
 Males, no. (%) | 43 (38.3) | 29 (37.1) | 14 (41.7) | 0.428 |
 Waist circumference, cm | 107 (102–114) | 106 (102–111) | 107.7 (103–115.5) | 0.188 |
 Weight, kg | 93 (84–102) | 92.2 (83–101) | 95.7 (86.5–102) | 0.272 |
 BMI, kg/m2 | 30.4 (28.8–32.9) | 30.2 (28.7–32.4) | 30.9 (28.8–33) | 0.374 |
 Systolic blood pressure mm Hg | 134 (123–146) | 133 (122–146) | 140.5 (127.5–149) | 0.352 |
 Diastolic blood pressure mm Hg | 76 (71–80) | 76 (70–80) | 75.5 (72–80) | 0.752 |
 Current smoker, no. (%) | 22 (19.6) | 12 (15.3) | 10 (29.4) | 0.156 |
 Type 2 diabetes, no. (%) | 16 (14.2) | 10 (21.2) | 6 (22) | 0.577 |
 FRS (%) b | 18.5 (11.7–30) | 15.8 (11.1–28.8) | 22.3 (15–30) | 0.022 |
Biochemical | ||||
 Total-c mg/dl | 189.8 (167.6–224.4) | 189.8 (167.8–226.6) | 190 (166.2–221.9) | 0.912 |
 LDL-ca mg/dl | 123.7 (100.2–155.8) | 122 (100.2–158.4) | 127 (98.4–155.8) | 0.898 |
 HDL-c mg/dl | 32.4 (26.9–37.1) | 34 (27.4–39.4) | 28.6 (23.9–35.5) | 0.032 |
 TG mg/dl | 162 (120.4–215.2) | 161.6 (124.8–213) | 170 (117.7–216.9) | 0.755 |
 Plasma glucose, mg/dl | 90 (84.6–106.2) | 90 (84.6–107.1) | 91.8 (84.6–106.2) | 0.832 |
 ALP, U/l | 47.5 (40–56.5) | 45 (38–52) | 52 (42–66) | 0.008 |
 ALT, U/l | 7.9 (5.6–10.1) | 8 (6.1–10.1) | 7.7 (5.6–11) | 0.919 |
 AST, U/l | 20 (16–26) | 20 (16–24) | 21.5 (14–27) | 0.933 |
 GGT, U/l | 36 (24–54.5) | 34 (22–51) | 37.5 (28–60) | 0.375 |
 FLIc | 82.3 (73.4–92.5) | 81.4 (70.6–92.1) | 87.6 (77.5–93.7) | 0.072 |